Mayo Clinic researchers have found a new way to more precisely detect and monitor brain cell activity during deep brain ...

Doctors have offered deep brain stimulation to Parkinson’s patients since 2002. But until now, devices have only provided ...

Here's what to know about deep brain stimulation for Parkinson's disease. Doctors have offered deep brain stimulation to Parkinson’s patients since 2002. But until now, devices have only ...

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of Parkinson disease.

Though DBS will not cure the progression of the disease, it will improve the quality of life of advanced PD patients.

The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s disease. The new technology is expected to be available in the US later in 2025.

Bhubaneswar: In a groundbreaking achievement, the Institute of Medical Sciences and SUM Hospital has succesfully conducted ...

U.S. Deep Brain Stimulation In Parkinson’s Disease Market Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis ...

BHUBANESWAR: In a first in the state, the Institute of Medical Sciences and SUM Hospital has successfully conducted deep ...

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

The FDA approved Medtronic's BrainSense Adaptive DBS and Electrode Identifier for Parkinson's, enhancing therapy personalization and clinic efficiency.